Etamsylate Causes Regression of Endometriosis Lesions in a Rat Model

In: Journal of Clinical Medical Research · 2025 · pp. 1–6 · doi:10.46889/jcmr.2025.6319 · W4416824197
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-08

Etamsylate administration induced regression of implanted endometrial tissues in a rat model of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Intraperitoneal injections of etamsylate in a suitable rat model of endometriosis produced regression of implanted endometrial tissues. Our results indicate that etamsylate is a promising candidate for endometriosis treatment.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK